Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

In 2012, the FDA approved Truvada, also made by Gilead Sciences, making it the first PrEP medication for HIV prevention in uninfected adults in the United States – but “even though PrEP has ...

It is already approved in multiple countries for the treatment of multi-drug-resistant HIV and is now entering the prevention space with unprecedented speed. That speed is critical.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

Health officials say 13% of people living with HIV don't know it. Doctors say the stigma is still one of the biggest reasons ...

2:38 Risk of 2,000 new HIV infections daily after US aid freeze, UN AIDS agency estimates The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Despite fewer new diagnoses, the number of those living with HIV surpassed 1 million in 2018 and 1.1 million in 2023.